Altimmune (ALT) had the highest return between April 1, 2017 and August 31, 2017 by a small-cap US stock, returning 25,199,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
Altimmune (ALT) | 4/1/2017 - 8/31/2017 | 25,199,900% |
Cryoport (CYRX) | 4/1/2017 - 8/31/2017 | 217.36% |
Abeona Therapeutics (ABEO) | 4/1/2017 - 8/31/2017 | 165.66% |
Puma Biotechnology (PBYI) | 4/1/2017 - 8/31/2017 | 147% |
BioLife Solutions (BLFS) | 4/1/2017 - 8/31/2017 | 130.1% |
Global Industrial (GIC) | 4/1/2017 - 8/31/2017 | 117.97% |
Intrepid Potash (IPI) | 4/1/2017 - 8/31/2017 | 115.7% |
Fennec Pharmaceuticals (FENC) | 4/1/2017 - 8/31/2017 | 115.38% |
CareDx (CDNA) | 4/1/2017 - 8/31/2017 | 104.29% |
Evotec SE ADR (EVO) | 4/1/2017 - 8/31/2017 | 102.65% |
Amtech Systems (ASYS) | 4/1/2017 - 8/31/2017 | 100.91% |
Everspin Technologies (MRAM) | 4/1/2017 - 8/31/2017 | 95.91% |
Trilogy Metals (TMQ) | 4/1/2017 - 8/31/2017 | 94.09% |
Weibo (WB) | 4/1/2017 - 8/31/2017 | 92.61% |
Verastem (VSTM) | 4/1/2017 - 8/31/2017 | 92.12% |
Nutex Health (NUTX) | 4/1/2017 - 8/31/2017 | 88.89% |
Lendingtree (TREE) | 4/1/2017 - 8/31/2017 | 83.37% |
Akebia Ther (AKBA) | 4/1/2017 - 8/31/2017 | 81.76% |
Lightwave Logic (LWLG) | 4/1/2017 - 8/31/2017 | 81.08% |
Ridgepost Capital (RPC) | 4/1/2017 - 8/31/2017 | 80% |
UroGen Pharma (URGN) | 4/1/2017 - 8/31/2017 | 79.59% |
Johnson Outdoors (JOUT) | 4/1/2017 - 8/31/2017 | 76.06% |
Tactile Systems Technology (TCMD) | 4/1/2017 - 8/31/2017 | 73.51% |
HIVE Digital Technologies (HIVE) | 4/1/2017 - 8/31/2017 | 71.43% |
MiMedx (MDXG) | 4/1/2017 - 8/31/2017 | 70.9% |
Small-cap stocks are treated as having a market cap between $300M and $2B.